Today’s best #FOAMed #FOAMcc finds (2 – Jan 17)

More top picks for you all....more coming next week! Enjoy. JW Big papers 5 days...is that too long?? URANGA - Take a look at this as ever fabulous bit of work from the crew at TBL. Looking at duration of Abx therapy in pneumonia. See here. FICE & Echo RAP measurement made easy! Here is... Continue Reading →

Advertisements

APRV – not so confusing anymore! #FOAMed

This is a modality of ventilation that seems to utilised more and more frequently in our ARDS patients with refractory hypoxaemia. To be honest, it can be a daunting mode if you don't understand the underlying principles behind it, so here is a guide to attempt to clear this up and make it more palatable,... Continue Reading →

Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial #FOAMed

This trial is worth a read. Courtesy of critical care (Click Icon) Basically They wanted to see whether sepsis-associated ARDS patients had better outcomes when given Hydrocortisone therapy. Methods They randomised patients to receive either hydrocortisone 50 mg every 6 h or placebo. What they demonstrated The patients who got hydrocortisone had significant improvement P:F ratios and... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: